CEREZYME
Live / Registered — Registered and renewed (as of 29 Oct 2025)
What this means for you
Registered since 15 Aug 1995. The owner can stop confusingly similar uses in the classes it covers; it stays on the register as long as the owner keeps up the maintenance filings (next due by 15 Aug 2025).
Record
- Serial number
- 74481041
- Registration number
- 1912218
- Mark type
- Word mark
- Filed
- 21 Jan 1994
- Published for opposition
- 20 Sept 1994
- Registered
- 15 Aug 1995
- Next maintenance due
- 15 Aug 2025
- Attorney of record
- Alexandra Kochian
Goods and services
- Class 005 — Pharmaceuticals: injectable pharmaceutical preparation to treat an enzyme deficiency caused by a genetic defect
Owner
- GENZYME CORPORATION, CAMBRIDGE, MA, US
- GENZYME THERAPEUTIC PRODUCTS LIMITED PARTNERSHIP, CAMBRIDGE, MA, US
- Genzyme Corporation, CAMBRIDGE, MA, US
- Genzyme Corporation, Cambridge, MA, US
- Genzyme Corporation, Cambridge, MA, US
Prosecution history
- 29 Oct 2025 — NOTICE OF ACCEPTANCE OF SEC. 8 & 9 - E-MAILED
- 29 Oct 2025 — REGISTERED AND RENEWED (THIRD RENEWAL - 10 YRS)
- 29 Oct 2025 — REGISTERED - SEC. 8 (10-YR) ACCEPTED/SEC. 9 GRANTED
- 29 Oct 2025 — CASE ASSIGNED TO POST REGISTRATION PARALEGAL
- 10 Jul 2025 — TEAS SECTION 8 & 9 RECEIVED
- 29 Jan 2025 — AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP
- 15 Aug 2024 — COURTESY REMINDER - SEC. 8 (10-YR)/SEC. 9 E-MAILED
- 08 Jan 2020 — REVIEW OF CORRESPONDENCE COMPLETE - ADDRESS UPDATED
- 10 Dec 2019 — CORRESPONDENCE RECEIVED IN LAW OFFICE
- 05 Apr 2017 — REVIEW OF CORRESPONDENCE COMPLETE - ADDRESS UPDATED
- 31 Jan 2017 — CORRESPONDENCE RECEIVED IN LAW OFFICE
- 21 Jan 2016 — NOTICE OF ACCEPTANCE OF SEC. 8 & 9 - E-MAILED
- 21 Jan 2016 — REGISTERED AND RENEWED (SECOND RENEWAL - 10 YRS)
- 21 Jan 2016 — REGISTERED - SEC. 8 (10-YR) ACCEPTED/SEC. 9 GRANTED
- 21 Jan 2016 — CASE ASSIGNED TO POST REGISTRATION PARALEGAL